Search Results - "Nantes, Oscar"

Tacrolimus induces short‐term but not long‐term clinical response in inflammatory bowel disease by Rodríguez‐Lago, Iago, Castro‐Poceiro, Jesús, Fernández‐Clotet, Agnès, Mesonero, Francisco, López‐Sanromán, Antonio, López‐García, Alicia, Márquez, Lucía, Clos‐Parals, Ariadna, Cañete, Fiorella, Vicuña, Miren, Nantes, Óscar, Merino, Olga, Matallana, Virginia, Gordillo, Jordi, Elorza, Ainara, Vicente, Raquel, Casanova, María José, Ferreiro‐Iglesias, Rocío, Pérez‐Galindo, Pablo, Benítez, José Manuel, Taxonera, Carlos, García, María José, Martín, Eduardo, Aguirre, Urko, Gisbert, Javier P., Rodríguez‐Lago, I., Elorza, A., Castro‐Poceiro, J., Fernández‐Clotet, A., Mesonero, F., López‐Sanromán, A., López‐García, A., Márquez, L., Clos‐Parals, A., Cañete, F., Vicuña, M., Nantes, O., Merino, O., Matallana, V., Gordillo, J., Vicente, R., Casanova, M. J., Gisbert, J. P., Ferreiro‐Iglesias, R., Pérez‐Galindo, P., Manuel Benítez, J., Taxonera, C., García, M. J., Martín, E., Aguirre, U., Calafat, M., Muñoz, F., Miquel‐Cusachs, J. O., Sáinz, E.

“…Summary Background Tacrolimus is a calcineurin inhibitor commonly used for prophylaxis of rejection in renal and liver transplantation. There are limited but…”
Get full text

Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease by Taxonera, Carlos, Ponferrada, Ángel, Riestra, Sabino, Bermejo, Fernando, Saro, Cristina, Martín-Arranz, María Dolores, Cabriada, José Luis, Barreiro-de Acosta, Manuel, de Castro, María Luisa, López-Serrano, Pilar, Barrio, Jesús, Suarez, Cristina, Iglesias, Eva, Argüelles-Arias, Federico, Ferrer, Isabel, Marín-Jiménez, Ignacio, Hernández-Camba, Alejandro, Bastida, Guillermo, Van Domselaar, Manuel, Martínez-Montiel, Pilar, Olivares, David, Rivero, Montserrat, Fernandez-Salazar, Luis, Nantes, Óscar, Merino, Olga, Alba, Cristina, Gisbert, Javier P

“…To assess the likelihood of detecting latent tuberculosis infection [LTBI] by the positive conversion of a serial tuberculin skin test [TST] at 1 year in…”
Get full text

Real-life experience with 4 years of golimumab persistence in ulcerative colitis patients by Iborra, Marisa, García-Morales, Natalia, Rubio, Saoia, Bertoletti, Federico, Calvo, Marta, Taxonera, Carlos, Boscá-Watts, Marta Maia, Sierra, Mónica, Mancenido, Noemí, Beltrán, Belén, Nantes Castillejo, Óscar, García-Planella, Esther, Vera, Isabel, Alba, Cristina, Martí-Aguado, David, Ballester, María Pilar, Cano-Sanz, Noelia, Pajares-Villarroya, Ramón, Cerrillo, Elena, Cañada, Antonio, Nos, Pilar

“…Golimumab has demonstrated its long-term efficacy and safety in ulcerative colitis in clinical trials, but no data of long-term persistence has been published…”
Get full text

Tofacitinib, useful option for the treatment of pyoderma gangrenosum in an ulcerative colitis patient by Salmón Olavarría, Pablo, Rubio Iturria, Saioa, Nantes Castillejo, Oscar

“…Pyoderma gangrenosum is a difficult to manage ulceronecrotising dermatosis associated with inflamatory bowel disease. In this article, we report a pyoderma…”
Get full text

Does capsule endoscopy impact clinical management in established Crohn's disease? by Elosua, Alfonso, Rullan, María, Rubio, Saioa, Oquiñena, Susana, Rodríguez, Cristina, Macías, Elena, Borda, Ana, Fernández-Urién, Ignacio, Nantes, Óscar

“…Capsule endoscopy (SBCE) has developed a relevant role in patients with established Crohn's Disease (CD). However, evaluation of the impact in clinical…”
Get full text

Early dose optimization of golimumab induces late response and long-term clinical benefit in moderately to severely active ulcerative colitis by Taxonera, Carlos, Iborra, Marisa, Bosca-Watts, Marta Maia, Rubio, Saioa, Nantes, Óscar, Higuera, Rebeca, Bertoletti, Federico, Martínez-Montiel, Pilar, Sierra-Ausin, Mónica, Manceñido, Noemí, Lázaro Pérez-Calle, José, Algaba, Alicia, Olivares, David, Alba, Cristina

“…Aim: To evaluate outcomes of early dose optimization of golimumab in ulcerative colitis (UC) patients with inadequate response to golimumab induction…”
Get full text

Clinical value of CT-P13 trough levels, an infliximab biosimilar, in the management of inflammatory bowel disease by Elosua González, Alfonso, Sanz Segura, Patricia, Oyón Lara, Daniel, López García, Santiago, Arroyo Villarino, Maria Teresa, Alcalá Escriche, Maria José, Ollero Domenche, Leticia, Rodríguez Gutiérrez, Cristina, Nantes Castillejo, Óscar

“…CT-P13 is a biosimilar drug of infliximab (IFX), effective in patients with inflammatory bowel disease (IBD). The monitoring of levels of IFX and anti-IFX…”
Get more information

Colectomy rate in ulcerative colitis 15 years after diagnosis: Results from the 2001-2003 Navarra cohort by Rodríguez, Cristina, Elosua, Alfonso, Prieto, Carlos, Pérez, Ernesto, Irisarri, Rebeca, Campillo, Ana, Rubio, Saioa, Nantes, Óscar, Angós, Ramón, Zozaya, José Manuel

“…Knowing the natural history of ulcerative colitis (UC) is essential to understand the course of the disease, assess the impact of different treatment…”
Get more information

Diagnostic and therapeutic management of eosinophilic oesophagitis in children and adults: Results from a Spanish registry of clinical practice by Lucendo, Alfredo J, Arias, Ángel, Molina-Infante, Javier, Rodríguez-Sánchez, Joaquín, Rodrigo, Luis, Nantes, Óscar, Pérez-Arellano, Elena, de la Riva, Susana, Pérez-Aisa, Ángeles, Barrio, Jesús

“…Abstract Background Eosinophilic oesophagitis has emerged as a common cause of oesophageal symptoms. Aims To document practice variation in care provided to…”
Get full text

Previous exposure to biologics and C-reactive protein are associated with the response to tacrolimus in inflammatory bowel disease by Rodríguez-Lago, Iago, Merino, Olga, Nantes, Óscar, Muñoz, Carmen, Aguirre, Urko, Cabriada, José Luis

“…Inflammatory bowel disease is a chronic disorder of the gastrointestinal tract. Tacrolimus is a calcineurin inhibitor used in the prophylaxis of rejection…”
Get full text

Long‐term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study by Chaparro, María, Hermida, Sandra, Acosta, Diana, Fernández‐Clotet, Agnès, Barreiro‐de Acosta, Manuel, Hernández Martínez, Álvaro, Arroyo, Maite, Bosca‐Watts, Marta Maia, Diz‐Lois Palomares, M. Teresa, Menchén, Luis, Martínez Cadilla, Jesús, Leo‐Carnerero, Eduardo, Muñoz Villafranca, Carmen, Sierra‐Ausín, Mónica, González‐Lama, Yago, Riestra, Sabino, Sendra Rumbeu, Pau, Cabello Tapia, M. José, García de la Filia, Irene, Vicente, Raquel, Ceballos, Daniel, Pajares Villarroya, Ramón, Ramírez de la Piscina, Patricia, Martín‐Arranz, María Dolores, Ramos, Laura, Ruiz‐Cerulla, Alexandra, Martínez‐Pérez, Teresa de Jesús, San Miguel Amelivia, Elena, Calvet, Xavier, Huguet, José María, Keco‐Huerga, Alma, Lorente Poyatos, Rufo H., Muñoz, José Fernando, Ponferrada‐Díaz, Ángel, Sicilia, Beatriz, Delgado‐Guillena, Pedro, Gómez Delgado, Elena, Rancel‐Medina, Francisco J., Alonso‐Galán, Horacio, Herreros, Belén, Rivero, Montserrat, Varela, Pilar, Bermejo, Fernando, García Sepulcre, Marifé, Gimeno‐Pitarch, Leticia, Kolle‐Casso, Lilyan, Márquez‐Mosquera, Lucía, Martínez Tirado, Pilar, Ramírez, Cynthia, Sesé Abizanda, Eva, Dueñas Sadornil, Carmen, Fernández Rosáenz, Hipólito, Gutiérrez Casbas, Ana, Madrigal Domínguez, Rosa Eva, Nantes Castillejo, Óscar, Ber Nieto, Yolanda, Botella Mateu, Belén, Frago Larramona, Santiago, López Serrano, Pilar, Rubio Mateos, José María, Torrá Alsina, Sandra, Iyo, Eduardo, Fernández Forcelledo, José Luis, Hernández, Luis, Rodríguez‐Grau, María Carmen, Monfort Miquel, David, Van Domselaar, Manuel, López Ramos, Carmen, Ruiz Barcia, M. Jesús, Gisbert, Javier P.

“…Summary Background Ustekinumab is approved for ulcerative colitis (UC). Aims To assess the durability of ustekinumab in patients with UC and its short‐term…”
Get full text

Transcultural adaptation and validation of the "Adult Eosinophilic Esophagitis Quality of Life Questionnaire" into Spanish by Lucendo, Alfredo J, Sánchez-Cazalilla, Marta, Molina-Infante, Javier, Pérez-Martínez, Isabel, Tenías, José M, Barrio, Jesús, Nantes, Óscar, Ciriza-de-los-Ríos, Constanza, Perelló, Antonia, Arias, Ángel

“…The "Adult Eosinophilic Esophagitis Quality of Life (EoE-QoL-A) Questionnaire" was developed in English as a valid, reliable, and disease-specific…”
Get full text

Gastrointestinal lesions and characteristics of acute gastrointestinal bleeding in acenocoumarol-treated patients by Nantes, Óscar, Zozaya, José Manuel, Montes, Ramón, Hermida, José

“…In the last few years, the number of anticoagulated patients has significantly increased and, as a consequence, so have hemorrhagic complications due to this…”
Get more information

The influence of polymorphisms of VKORC1 and CYP2C9 on major gastrointestinal bleeding risk in anticoagulated patients by Montes, Ramón, Nantes, Óscar, Alonso, Álvaro, Zozaya, José M., Hermida, José

“…Summary The VKORC1 c.−1639G>A and CYP2C9 c.430C>T and c.1075A>C polymorphisms have been associated with increased sensitivity to oral anticoagulants. However,…”
Get full text

Adalimumab treatment of anti-TNF-naïve patients with ulcerative colitis: Deep remission and response factors by Muñoz-Villafranca, Carmen, Ortiz de Zarate, Jone, Arreba, Paz, Higuera, Rebeca, Gómez, Laura, Ibáñez, Sylvia, Merino, Olga, Muñagorri, Ana, Ogueta, Maria, Rodriguez, Cristina, Nantes, Oscar, Ramirez de la Piscina, Patricia, Rodríguez, Iago, Bernal, Antonio, Arévalo, Juan, Cabriada, Jose

“…Adalimumab is the second tumour necrosis factor antagonist (anti-TNF) adopted for the treatment of ulcerative colitis. Clinical data from naïve patients are…”
Get full text

Use of capsule endoscopy in inflammatory bowel disease in clinical practice in Spain. Results from a national survey by Elosua González, Alfonso, Nantes Castillejo, Óscar, Fernández-Urién Sainz, Ignacio, López-García, Alicia, Murcia Pomares, Óscar, Zabana, Yamile

“…Small bowel capsule endoscopy (SBCE) is a non-invasive diagnostic technique whose use in inflammatory bowel disease (IBD) has spread. A panenteric capsule,…”
Get more information

Intestinal myeloid sarcoma: an uncommon presentation of an exceptional disease by Valdivielso Cortázar, Eduardo, Bolado Concejo, Federico, Vila Costas, Juan José, Nantes Castillejo, Óscar, Jiménez Pérez, Francisco Javier, Miranda Murúa, María del Coro, Jiménez Mendióroz, Francisco Javier

Get more information

Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real‐world efficacy from the EoE CONNECT registry by Laserna‐Mendieta, Emilio J., Navarro, Pilar, Casabona‐Francés, Sergio, Savarino, Edoardo V., Amorena, Edurne, Pérez‐Martínez, Isabel, Guagnozzi, Danila, Blas‐Jhon, Leonardo, Betoré, Elena, Guardiola‐Arévalo, Antonio, Pellegatta, Gaia, Krarup, Anne Lund, Perello, Antonia, Barrio, Jesús, Gutiérrez‐Junquera, Carolina, Teruel Sánchez‐Vegazo, Carlos, Fernández‐Fernández, Sonia, Naves, Juan Enrique, Oliva, Salvatore, Rodríguez‐Oballe, Juan Armando, Carrión, Silvia, Espina, Silvia, Llorente Barrio, Mónica, Masiques‐Mas, Maria Lluisa, Dainese, Raffaella, Feo‐Ortega, Sara, Martín‐Dominguez, Verónica, Fernández‐Pacheco, Jennifer, Pérez‐Fernández, Maria Teresa, Ghisa, Matteo, Maniero, Daria, Nantes‐Castillejo, Óscar, Nicolay‐Maneru, Julia, Suárez, Adolfo, Maray, Iván, Llerena‐Castro, Ronald, Ortega‐Larrodé, Adriana, Alcedo, Javier, Granja Navacerrada, Alicia, Racca, Francesca, Santander, Cecilio, Arias, Ángel, Lucendo, Alfredo J.

“…Background Swallowed topical corticosteroids (tC) are common therapy for patients with eosinophilic esophagitis (EoE). Widely heterogeneous results have…”
Get full text

Real‐world outcomes of switching from adalimumab originator to adalimumab biosimilar in patients with inflammatory bowel disease: The ADA‐SWITCH study by Casanova, María José, Nantes, Óscar, Varela, Pilar, Vela‐González, Milagros, Rivero, Montserrat, Sierra‐Gabarda, Olivia, Riestra, Sabino, Barreiro‐de Acosta, Manuel, Martín‐Rodríguez, María del Mar, Gargallo‐Puyuelo, Carla Jerusalén, Reygosa, Cristina, Muñoz, Roser, Filia‐Molina, Irene García, Núñez‐Ortiz, Andrea, Kolle, Lilyan, Calafat, Margalida, Huguet, José María, Iglesias‐Flores, Eva, Martínez‐Pérez, Teresa de Jesús, Bosch, Orencio, Duque‐Alcorta, José María, Frago‐Larramona, Santiago, Van Domselaar, Manuel, González‐Cosano, Víctor Manuel, Bujanda, Luis, Rubio, Saioa, Mancebo, Alejo, Castro, Beatriz, García‐López, Santiago, Francisco, Ruth, Nieto‐García, Laura, Laredo, Viviana, Gutiérrez‐Casbas, Ana, Mesonero, Francisco, Leo‐Carnerero, Eduardo, Cañete, Fiorella, Ruiz, Lucía, Gros, Beatriz, Moral‐Martínez, María, Rodríguez, Cristina, Chaparro, María, Gisbert, Javier P.

“…Summary Background and Aims Data on the outcomes after switching from adalimumab (ADA) originator to ADA biosimilar are limited. The aim was to compare the…”
Get full text

Clinical outcome after anti‐tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long‐term study by Casanova, María José, Chaparro, María, Nantes, Óscar, Benítez, José Manuel, Rojas‐Feria, María, Castro‐Poceiro, Jesús, Huguet, José María, Martín‐Cardona, Albert, Aicart‐Ramos, Marta, Tosca, Joan, Martín‐Rodríguez, María del Mar, González‐Muñoza, Carlos, Mañosa, Miriam, Leo‐Carnerero, Eduardo, Lamuela‐Calvo, Luis Javier, Pérez‐Martínez, Isabel, Bujanda, Luis, Hinojosa, Joaquín, Pajares, Ramón, Argüelles‐Arias, Federico, Pérez‐Calle, José Lázaro, Rodríguez‐González, Gloria Esther, Guardiola, Jordi, Barreiro‐de Acosta, Manuel, Gisbert, Javier P., Bermejo, F., Barrio, J., Beltrán, B., Gomollón, F., Lorente, R., Gutierrez, A., Domínguez‐Cajal, M., Dueñas, C., Ponferrada‐Díaz, A., Van Domselaar, M., Ramírez‐de la Piscina, P., Ramos, L., Almela, P., Navarro‐Llavat, M., Botella, B., Castaño‐Milla, C., Rodríguez, C., Iglesias‐Flores, E., Serrano‐Muñoz, M. J., Ricart, E., Monzó, A., Esteve, M., Garrido, E., Mínguez, M., Cabello‐Tapia, M. J., García‐Planella, E., Domènech, E., Núñez‐Ortiz, A., García‐López, S.

“…Summary Background The long‐term outcome of patients after antitumour necrosis factor alpha (anti‐TNF) discontinuation is not well known. Aims To assess the…”
Get full text